Bayesian sample size calculation for estimation of the difference between two binomial proportions

被引:3
作者
Pezeshk, Hamid [1 ,2 ,3 ]
Nematollahi, Nader [4 ]
Maroufy, Vahed [5 ]
Marriott, Paul [5 ]
Gittins, John [6 ]
机构
[1] Univ Tehran, Sch Math Stat & Comp Sci, Tehran 141556455, Iran
[2] Univ Tehran, Ctr Excellence Biomath, Tehran 141556455, Iran
[3] Inst Res Fundamental Sci IPM, Tehran, Iran
[4] Univ Allameh Tabatabaie, Dept Stat, Tehran, Iran
[5] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
[6] Univ Oxford, Dept Stat, Oxford OX1 3TG, England
关键词
sample size determination; clinical trial; fully Bayesian approach; binomial distribution; expected net benefit; Dirichlet distribution; COST-BENEFIT APPROACH; CLINICAL-TRIALS; EXPERIMENTATION;
D O I
10.1177/0962280211399562
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In this study, we discuss a decision theoretic or fully Bayesian approach to the sample size question in clinical trials with binary responses. Data are assumed to come from two binomial distributions. A Dirichlet distribution is assumed to describe prior knowledge of the two success probabilities p(1) and p(2). The parameter of interest is p=p(1)-p(2). The optimal size of the trial is obtained by maximising the expected net benefit function. The methodology presented in this article extends previous work by the assumption of dependent prior distributions for p(1) and p(2).
引用
收藏
页码:598 / 611
页数:14
相关论文
共 21 条
  • [1] Adcock CJ, 1997, J ROY STAT SOC D-STA, V46, P261
  • [2] THE BAYESIAN-APPROACH TO DETERMINATION OF SAMPLE SIZES - SOME COMMENTS ON THE PAPER BY JOSEPH, WOLFSON AND DU BERGER
    ADCOCK, CJ
    [J]. STATISTICIAN, 1995, 44 (02): : 155 - 161
  • [3] A BAYESIAN-APPROACH TO CALCULATING SAMPLE SIZES
    ADCOCK, CJ
    [J]. STATISTICIAN, 1988, 37 (4-5): : 433 - 439
  • [4] [Anonymous], 1992, J ROY STAT SOC D STA, DOI DOI 10.2307/2349003
  • [5] [Anonymous], J ROY STAT SOC D STA, DOI DOI 10.2307/2348439
  • [6] [Anonymous], 1926, HYPERGEOMETRIQUES HY
  • [7] How large should a clinical trial be?
    Gittins, J
    Pezeshk, H
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 2000, 49 : 177 - 187
  • [8] Gittins J C, 2002, J Biopharm Stat, V12, P535, DOI 10.1081/BIP-120016234
  • [9] GRUNDY PM, 1956, J ROY STAT SOC B, V18, P32
  • [10] Joseph L, 1997, STAT MED, V16, P769, DOI 10.1002/(SICI)1097-0258(19970415)16:7<769::AID-SIM495>3.0.CO